Delivery Order SPE2DB22D3004-SPE2DB23FPX70

Award Date 4/20/23
Potential Completion Date 4/21/23
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.16 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. This award is made under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,370.84 delivery order is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdose. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,286.36 firm fixed-price delivery order is for the supply of 4 mg nasal spray naloxone hydrochloride, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of July 16, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,135.04 firm fixed-price delivery order is for the procurement of 4,559,306 units of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the delivery of 4,559,130 units of 4 mg naloxone hydrochloride nasal spray to the Defense Logistics Agency (DLA). The award, valued at $6,238.14, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $6,604.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4 mg Naloxone Hydrochloride nasal spray, a medication used to treat opioid overdose. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,355 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, which is used to treat opioid overdose. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,685.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a period of performance through February 27, 2025 and utilizes a firm fixed-price pricing structure. The award is not associated with a set-aside program and represents an open competition....
The federal contract award is for the delivery of 4,561,847,733 units of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdose. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $10,829.60, is a firm fixed-price delivery order with an ultimate completion date of August 18, 2023. Amerisourcebergen Drug Corp is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,472.91 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, which is a critical medication used to treat opioid overdose. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB23FPX70
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdose. The contract, valued at $6,274.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract vehicle used to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have any set-aside designation, indicating open competition. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Generated 5/9/25, 9:45 AM